LIMELIGHT
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Jul 2020)
What this means for you
This application is over — abandoned 27 Jul 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87253414
- Mark type
- Stylized text
- Filed
- 01 Dec 2016
- Published for opposition
- 25 Apr 2017
- Abandoned
- 27 Jul 2020
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders, all of the above excluding lyme disease
- Class 042 — Scientific and technological services: Research and development of human therapeutics; biopharmaceutical research and development services
Owner
- Limelight Bio, Inc., New York, NY, US
- Limelight Bio, Inc., New York, NY, US
Prosecution history
- 27 Jul 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Jul 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 31 Dec 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Dec 2019 — SOU EXTENSION 5 GRANTED
- 18 Dec 2019 — SOU EXTENSION 5 FILED
- 30 Dec 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Dec 2019 — SOU TEAS EXTENSION RECEIVED
- 23 Nov 2019 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 15 Jun 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jun 2019 — SOU EXTENSION 4 GRANTED
- 13 Jun 2019 — SOU EXTENSION 4 FILED
- 13 Jun 2019 — SOU TEAS EXTENSION RECEIVED
- 12 Dec 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2018 — SOU EXTENSION 3 GRANTED
- 10 Dec 2018 — SOU EXTENSION 3 FILED